Skip to main content
logo
HEM Pharma Inc. (KOSDAQ:376270)
South Korea flag South Korea · Delayed Price · Currency is KRW
38,900
-1,200 (-2.99%)
At close: Aug 24, 2026

HEM Pharma Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Net Income
-25,608-23,842-7,646
Depreciation & Amortization
2,6952,5952,422
Loss (Gain) From Sale of Assets
3.477.02-
Asset Writedown & Restructuring Costs
534.93534.93-
Loss (Gain) From Sale of Investments
-27.19-30.47-24.89
Stock-Based Compensation
877.73929.21915.56
Provision & Write-off of Bad Debts
0.150.14-
Other Operating Activities
8,0317,814418.39
Change in Accounts Receivable
905.632,708-2,568
Change in Inventory
96.83-504.96-781.57
Change in Accounts Payable
468.97410.61549.43
Change in Other Net Operating Assets
5,2881,033-964.77
Operating Cash Flow
-6,733-8,345-7,680
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Capital Expenditures
-11,054-9,755-4,687
Sale of Property, Plant & Equipment
0.1816.18-
Cash Acquisitions
-106.19-106.19-
Sale (Purchase) of Intangibles
-314.8-229.87-110.97
Investment in Securities
3,6774,504-4,675
Other Investing Activities
-0-0-
Investing Cash Flow
-7,827-5,571-9,473

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Short-Term Debt Issued
-1,400-
Long-Term Debt Issued
-19,218-
Total Debt Issued
18,79620,618-
Long-Term Debt Repaid
--890.94-324.36
Net Debt Issued (Repaid)
17,85719,727-324.36
Issuance of Common Stock
1,6911,70716,512
Other Financing Activities
-6.94-8.06-915.47
Financing Cash Flow
19,54121,42515,272

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Foreign Exchange Rate Adjustments
129.21.313.91
Miscellaneous Cash Flow Adjustments
---0
Net Cash Flow
5,1107,511-1,877

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Free Cash Flow
-17,787-18,100-12,367
Free Cash Flow Growth
---
Free Cash Flow Margin
-123.42%-139.45%-82.08%
Free Cash Flow Per Share
-2509.86-2572.96-1945.77
Levered Free Cash Flow
5,0174,409-
Unlevered Free Cash Flow
5,6224,814-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Cash Interest Paid
434.39418.68258.79
Cash Income Tax Paid
22.8120.7-22.47
Change in Working Capital
6,7593,647-3,765